Black Diamond Therapeutics, Inc. · NASDAQ:BDTX
Black Diamond Therapeutics, Inc. shareholders
As of Sep 30, 2026, 107 institutions reported holding Black Diamond Therapeutics, Inc., 65.8% of its shares. Largest: NEA Management Company, LLC, BlackRock and T. Rowe Price. New holders, exits, insiders and big stakes, each with its filing.
| Holder | Shares | % of Black Diamond Therapeutics, Inc. | Change | Filed |
|---|---|---|---|---|
| NEA Management Company, LLC | 4.45M | 7.7% | no change | Nov 16, 2026 |
| BlackRock | 4.3M | 7.5% | +384K | Nov 13, 2026 |
| T. Rowe Price | 3.96M | 6.9% | −103K | Nov 16, 2026 |
| Vanguard | 2.9M | 5.0% | +38,706 | Nov 13, 2026 |
| Acadian Asset Management LLC | 2.35M | 4.1% | no change | Nov 9, 2026 |
| Bank of America | 2.05M | 3.6% | +1.63M | Nov 16, 2026 |
| Defilade Capital Management, L.P. | 1.77M | 3.1% | +95,949 | Nov 16, 2026 |
| Renaissance Technologies | 1.65M | 2.9% | −310K | Nov 12, 2026 |
| Geode Capital | 1.25M | 2.2% | +28,143 | Nov 6, 2026 |
| Marshall Wace, LLP | 1.18M | 2.0% | +280K | Nov 13, 2026 |